News in the Life Sciences Industry

SUZHOU and HANGZHOU, China, April 20, 2020 /PRNewswire/ -- Transcenta Holding Limited. ("Transcenta"), a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacturing, today announced that its subsidiary Mabspace Biosciences (Suzhou)... Read more ››

Company is actively developing and scaling manufacturing processes for 18-MC and LSD APIs to be used in the company's future drug trials

SUZHOU, China, April 19, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 1801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major... Read more ››

SILVER SPRING, Md., April 16, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration announced a further expansion of COVID-19 testing options through the recognition that spun synthetic swabs - with a design similar to Q-tips - could be used to test patients by collecting a sample from the... Read more ››

HONG KONG, April 14, 2020 /PRNewswire/ -- Insilico Medicine is pleased to announce that it has entered into a research collaboration with... Read more ››

SILVER SPRING, Md., April 14, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

SILVER SPRING, Md., April 13, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

SUZHOU, China, April 14, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platform, announced that WuXi Biologics (Suzhou) Co., Ltd. has successfully passed its first GMP inspection by the European Medicines Agency (EMA),... Read more ››

SHIJIAZHUANG, China, April 13, 2020 /PRNewswire/ -- Recently, Shijiazhuang Yiling Pharmaceutical Co, Ltd. announced that the ministry of foreign affairs of the People's Republic of China has purchased 700,000 boxes of Lianhua Qingwen and distribute them to each Chinese embassy. The health packages... Read more ››

SEONGNAM, South Korea, April 9, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced the interim data from the first cohort in the phase 2a study of BBT-401, an experimental drug for the treatment of ulcerative... Read more ››